These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7564805)

  • 1. Treatment of tuberculosis in developing countries.
    Elliott AM; Mwinga AG; Foster SD
    Lancet; 1995 Oct; 346(8982):1098-9. PubMed ID: 7564805
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of tuberculosis in developing countries.
    Pozniak A
    Lancet; 1995 Oct; 346(8982):1099. PubMed ID: 7564806
    [No Abstract]   [Full Text] [Related]  

  • 3. Severe hypersensitivity reactions among HIV-seropositive patients with tuberculosis treated with thioacetazone.
    Wkly Epidemiol Rec; 1992 Jan; 67(1-2):1-3. PubMed ID: 1371055
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of tuberculosis in developing countries.
    van Bogaert LJ
    Lancet; 1995 Oct; 346(8982):1099-100. PubMed ID: 7564807
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of thiacetazone.
    Foster S; Kelly P
    Lancet; 1995 Jan; 345(8941):62-3. PubMed ID: 7528311
    [No Abstract]   [Full Text] [Related]  

  • 6. Further consequences of thioacetazone-induced cutaneous reactions.
    Lawn SD; Griffin GE
    Int J Tuberc Lung Dis; 2000 Jan; 4(1):92-3. PubMed ID: 10654652
    [No Abstract]   [Full Text] [Related]  

  • 7. The influence of HIV status on single and multiple drug reactions to antituberculous therapy in Africa.
    Pozniak AL; MacLeod GA; Mahari M; Legg W; Weinberg J
    AIDS; 1992 Aug; 6(8):809-14. PubMed ID: 1384557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wrong drug used for tuberculosis.
    Kelly PM
    Int J Tuberc Lung Dis; 1997 Aug; 1(4):385. PubMed ID: 9432398
    [No Abstract]   [Full Text] [Related]  

  • 9. Rebuttal: time to call a halt to emotions in the assessment of thioacetazone.
    Rieder HL; Enarson DA
    Tuber Lung Dis; 1996 Apr; 77(2):109-11. PubMed ID: 8762843
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacovigilance and tuberculosis: applying the lessons of thioacetazone.
    Falzon D; Hill G; Pal SN; Suwankesawong W; Jaramillo E
    Bull World Health Organ; 2014 Dec; 92(12):918-9. PubMed ID: 25552777
    [No Abstract]   [Full Text] [Related]  

  • 11. Thiacetazone: time to call a halt? Considerations on the use of thiacetazone in African populations with a high prevalence of human immunodeficiency virus infection.
    Elliott AM; Foster SD
    Tuber Lung Dis; 1996 Feb; 77(1):27-9. PubMed ID: 8733410
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of thiacetazone.
    Wilkinson D; Moore D
    Lancet; 1995 Jan; 345(8941):63. PubMed ID: 7528313
    [No Abstract]   [Full Text] [Related]  

  • 13. Multiforme skin lesions in Yekatit 12 Hospital, 1976-1994.
    Gessesse B; Mulugeta E
    Ethiop Med J; 2000 Jan; 38(1):43-7. PubMed ID: 11144879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous hypersensitivity reactions due to thiacetazone in the treatment of tuberculosis in Zambian children infected with HIV-I.
    Chintu C; Luo C; Bhat G; Raviglione M; DuPont H; Zumla A
    Arch Dis Child; 1993 May; 68(5):665-8. PubMed ID: 7686737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous hypersensitivity reactions to thiacetazone, HIV infection and thiacetazone concentrations in plasma.
    Watkins WM; Mungai M; Muhia DK; Mberu EK; Gathua S; Winstanley PA; Gilks CF; Nunn P
    Br J Clin Pharmacol; 1996 Feb; 41(2):160-2. PubMed ID: 8838444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug regimen for tuberculosis without thiacetazone and streptomycin.
    Biddulph J
    Lancet; 1991 May; 337(8750):1174. PubMed ID: 1709250
    [No Abstract]   [Full Text] [Related]  

  • 17. Risk factors for adverse drug reactions during thiacetazone treatment of pulmonary tuberculosis in human immunodeficiency virus infected adults.
    Okwera A; Johnson JL; Vjecha MJ; Wolski K; Whalen CC; Hom D; Huebner R; Mugerwa RD; Ellner JJ
    Int J Tuberc Lung Dis; 1997 Oct; 1(5):441-5. PubMed ID: 9441099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased recurrence of tuberculosis in HIV-1-infected patients in Kenya.
    Hawken M; Nunn P; Gathua S; Brindle R; Godfrey-Faussett P; Githui W; Odhiambo J; Batchelor B; Gilks C; Morris J
    Lancet; 1993 Aug; 342(8867):332-7. PubMed ID: 7687729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse reaction to antimycobacterials administered as a combination tablet with no reaction to the same drugs in isolation.
    Kingston M; Childs K; Carlin E
    Sex Transm Infect; 2001 Oct; 77(5):392-3. PubMed ID: 11588298
    [No Abstract]   [Full Text] [Related]  

  • 20. Cutaneous hypersensitivity reactions due to thiacetazone in HIV-1 seropositive patients treated for tuberculosis.
    Nunn P; Kibuga D; Gathua S; Brindle R; Imalingat A; Wasunna K; Lucas S; Gilks C; Omwega M; Were J
    Lancet; 1991 Mar; 337(8742):627-30. PubMed ID: 1705647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.